Literature DB >> 910355

Malignancy in end-stage renal disease.

R F Slifkin, J Goldberg, M S Neff, A Baez, N Mattoo, S Gupta.   

Abstract

Entities:  

Mesh:

Year:  1977        PMID: 910355     DOI: 10.1097/00002480-197700230-00010

Source DB:  PubMed          Journal:  Trans Am Soc Artif Intern Organs        ISSN: 0066-0078


× No keyword cloud information.
  9 in total

1.  Bladder cancer in a patient on long-term haemodialysis.

Authors:  H Hadatsuki; I Sasagawa; H Suzuki; H Yaguchi; A Mutoh; Y Kubota; T Nakada
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

Review 2.  The use of vaccines in renal failure.

Authors:  D W Johnson; S J Fleming
Journal:  Clin Pharmacokinet       Date:  1992-06       Impact factor: 6.447

3.  Cancer and chronic renal failure.

Authors:  G Digenis; A Pierratos; D G Oreopoulos
Journal:  CMAJ       Date:  1986-07-01       Impact factor: 8.262

Review 4.  Depressed immunity and the development of cancer.

Authors:  I Penn
Journal:  Clin Exp Immunol       Date:  1981-12       Impact factor: 4.330

5.  Tumour induction as a consequence of immunosuppression after renal transplantation.

Authors:  P Winter; G Schoeneich; W D Miersch; H U Klehr
Journal:  Int Urol Nephrol       Date:  1997       Impact factor: 2.370

6.  Serum tumour markers in renal failure.

Authors:  N Arik; B Adam; T Akpolat; K Haşil; S Tabak
Journal:  Int Urol Nephrol       Date:  1996       Impact factor: 2.370

7.  Increased incidence of neoplasia in chronic renal failure (20-year experience).

Authors:  Kuddusi Cengiz
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

8.  Cancer in patients receiving dialysis.

Authors:  L J Kinlen; J B Eastwood; D N Kerr; J F Moorhead; D O Oliver; B H Robinson; H E de Wardener; A J Wing
Journal:  Br Med J       Date:  1980-06-14

9.  Malignant tumors in patients with end stage renal failure undergoing renal replacement therapy.

Authors:  Grzegorz Kade; Arkadiusz Lubas; Lubomir Bodnar; Cezary Szczylik; Zofia Wańkowicz
Journal:  Contemp Oncol (Pozn)       Date:  2012-11-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.